Sage Journals: Discover world-class research

Abstract

The human placenta is an important source of stem cells that can be easily collected without ethical concerns since it is usually discarded after childbirth. In this study, we analyzed the amniotic membrane (AM) from the human placenta with the aim of mapping different regions with respect to their morpho-functional features and regenerative potential. AMs were obtained from 24 healthy women, undergoing a caesarean section, and mapped into 4 different regions according to their position in relation to the umbilical cord: the central, intermediate, peripheral, and reflected areas. We carried out a multiparametric analysis focusing our attention on amniotic epithelial cells (AECs). Our results revealed that AECs, isolated from the different areas, are a heterogeneous cell population with different pluripotency and proliferation marker expression (octamer-binding transcription factor 4 [OCT-4], tyrosine-protein kinase KIT [c-KIT], sex determining region Y-box 2 [SOX-2], α-fetoprotein, cyclic AMP response element binding [CREB] protein, and phosphorylated active form of CREB [p-CREB]), proliferative ability, and osteogenic potential. Our investigation discloses interesting findings that could be useful for increasing the efficiency of AM isolation and application for therapeutic purposes.

Keywords

human term placenta amniotic membrane amniotic epithelial cells placenta stem cells

Introduction

The human placenta is a discoid-shaped organ made up of both fetal and maternal components. The fetal components include the placental disc, the amniotic and chorionic membranes (often referred to as the fetal membranes), the chorionic villi, and the umbilical cord¹; the maternal side is comprised of the decidua¹. Different cell types with stem/progenitor properties have been isolated from the maternal decidua^2,3, the umbilical cord matrix^4,5, the chorionic villi^6
–8, and the fetal membranes^1,9.

Of particular interest is the human amniotic membrane (AM) that has a long history of clinical applications. The AM has proven to be a precious resource for tissue engineering and has been shown to possess anti-inflammatory properties and low immunogenicity^10
–12, making it an attractive and widely studied tissue for diverse therapeutic applications^13
–15.

More recently, decellularized AM has been employed for postinfarct left ventricular remodeling¹⁶ and for the repair of an oroantral communication¹⁷, thus generating new questions as to the therapeutic potential of the different regions and/or cells in the AM. Indeed, only a handful of reports have characterized and studied the phenotype of the cells comprising the AM in situ^18,19. A recently published paper demonstrated that placental and reflected AM differ in morphology and functional activity, as the placental region has significantly higher mitochondrial activity, yet significantly fewer reactive oxygen species (ROS)²⁰.

The AM is composed of 2 layers, an epithelial layer, containing 2 epithelial cell types of cuboid or columnar shape called amniotic epithelial cells (AECs), and a stromal avascularized layer, containing amniotic mesenchymal stromal cells (AMSCs)²¹. Evidence of plasticity of AECs has substantiated their interest for various applications in regenerative medicine. In vitro, AECs have been shown to differentiate into cells of all the 3 germ layers²¹, and after 5 to 10 passages in culture, they change their phenotype from cuboidal epithelial to mesenchymal and fibroblast-like²² and reduce their differentiation potential^23,24. AECs have also been shown to express pluripotency markers, including stage-specific embryonic antigen-4 (SSEA-4)²⁵, octamer-binding transcription factor 4 (Oct-4), Nanog, sex-determining region Y-box 2 (Sox2), and Rex-1²⁶.

Thus, given the reports showing AEC plasticity and stemness, the aim of this study was to map the human AM under physiological conditions with respect to the structure and phenotype, to analyze AECs in situ from 4 different areas of AM, and to perform CFU and differentiation assays after cell isolation to identify the region where AECs with the highest stemness potential/characteristics could be found.

Materials and Methods

Subjects and Sample Preparation

Human term placentas (n = 24) were collected from healthy women (mean age ± standard deviation [SD] = 31.4 ± 5.2) after vaginal delivery or caesarean section at the Fondazione Poliambulanza-Istituto Ospedaliero, Brescia, or at the Hospital SS. Annunziata, Chieti. Samples were collected after obtaining informed written consent according to the guidelines set by the Ethics Committee for the Institution of Catholic Hospitals or the G. d’Annunzio University of Chieti–Pescara.

We dissected the placentas to isolate samples of AM from 4 different regions according to their position relative to the umbilical cord. The first area, closer to umbilical cord, was named the central area; the second, in the middle, was considered the intermediate area; the third was named the peripheral area; and the fourth, the reflected area, corresponded to the chorion laeve.

Light and Electron Microscopy Procedures

Samples of AM were fixed with 4% formaldehyde (Carlo Erba Reagents, Milan, Italy) or 3% paraformaldehyde (PFA) in 1× phosphate-buffered saline (PBS) for 2 to 3 h. Both groups of samples were then dehydrated in a series of graded increases in alcohol concentrations, embedded in paraffin, and cut on a microtome (Leica, RM 2265, Nussloch, Germany). Sections were routinely stained with hematoxylin–eosin (H&E) and Mallory trichrome staining solutions, mounted in Bio Mount, and observed under a ZEISS Axioskop 40 (Carl Zeiss, Gottingen, Germany) light microscope equipped with a Coolsnap videocamera (Photometrics, Tucson, AZ, USA).

For electron microscopy, samples were fixed with 2.5% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.2–7.4, for 2 to 3 h at 4 °C. They were washed in cacodylate buffer and postfixed in 1% osmium tetroxide for 1 to 2 h at 4 °C. After dehydration in increasing alcohol gradients, samples were embedded in Spurr resin and cut at the ultramicrotome (C. Reichert-Jung Ultracut, Wien, Austria). Semithin sections were stained with 1% toluidine blue for light microscopy analysis. Observations were carried out under a ZEISS Axioskop 40 (Carl Zeiss) light microscope equipped with a Coolsnap videocamera (Photometrics).

Immunohistochemistry

The expression of different markers of pluripotency and proliferation of the 4 placental areas was evaluated through immunohistochemistry. The tissue sections fixed in 3% PFA were deparaffinized with Bio-Clear (BioOptica, Milano, Italy), dehydrated in decreasing alcohol gradients, and washed in distilled water. After washing with PBS, antigenic unmasking was performed with 0.05% trypsin in PBS for 5 min. Sections were then incubated with Ultravision Hydrogen Peroxide Block (Ultravision Quanto Detection System, Thermo Scientific) for 10 min and washed with PBS. After blocking with Ultravision Protein Block for 5 min, sections were incubated with the primary antibody overnight at 4 °C. The working dilutions were 1:500 for OCT-4 (polyclonal antibody rabbit, Thermo Scientific), c-KIT (monoclonal antibody mouse, Santa Cruz, Dallas, TX, USA), and α-fetoprotein (monoclonal antibody mouse, Thermo Scientific); 1:600 for SOX-2 (monoclonal antibody mouse, Thermo Scientific); and 1:400 for CREB (monoclonal antibody rabbit, Cell Signaling, Danvers, MA, USA) and phosphorylated active form of CREB (p-CREB; polyclonal antibody rabbit, Cell Signaling). After washing with PBS, the sections were incubated with Primary Antibody Amplifier Quanto (Ultravision Quanto Detection System, Thermo Scientific, Runcorn, UK) for 10 min followed by HRP Polimer Quanto (Ultravision Quanto Detection System, Thermo Scientific) for 10 min. The reaction was developed by incubating sections with the Quanto Chromogen-Dab Quanto Substrate mix (Ultravision Quanto Detection System, Thermo Scientific) for 5 min. Slides were mounted with glycerol and observed under a ZEISS Axioskop 40 (Carl Zeiss) light microscope, equipped with a Coolsnap videocamera (Photometrics). MetaMorph Software System (Universal Imaging Inc., Bedford Hills, NY, USA; Molecular Devices Sunnyvale, CA, USA; Crisel Instruments, Rome, Italy) was used to acquire, visualize, and analyze digital images.

In some cases, cytospins of purified AECs were fixed in 3% PFA in 1× PBS for 20 min at 4 °C. All cytospins were permeabilized with 0.1% Triton in 1× PBS for 2 min and incubated with anti-OCT-4, c-KIT, SOX-2, α-fetoprotein, and CREB monoclonal/polyclonal antibodies and further processed following the above-mentioned immunohistochemistry protocol.

Morphometric Analysis

Tissue sections, cytospins, and toluidine blue-stained semithin sections were subjected to morphometric computerized image analysis. MetaMorph Software System (Universal Imaging Inc., Molecular Devices Crisel Instruments) was used to acquire digital images, to quantitate the amount of labeling and the number of positive cells, and to measure the extent of cell area occupied by granules. Morphometric computerized analysis of the specific areas was performed after calibrating the MetaMorph 6.1r6 program (Universal Imaging Inc.,) for the objective lens magnification used (×20). Image analysis of sections processed for immunohistochemistry and of semithin sections was performed by making 3 shots at ×20 and ×40 magnification for each area and by setting the range to measure the positivity for each antibody. The selected area for each sample was 3,000 μm² for immunohistochemistry reactions and 2,400 μm² for semithin sections. Image analysis of the amount of labeling in immunohistochemistry reactions and of cell granules area in semithin sections was performed by establishing a discrimination threshold and by setting the desired intensity of positive AECs and AMSCs and granules present inside the AECs. The threshold granule area was measured for each cell and expressed as a percentage of whole cell area. The threshold range settings were kept constant for the different experimental groups. MetaMorph data were logged to Microsoft Excel to calculate mean values and SD.

Isolation of Human Amniotic Epithelial Cells (hAECs)

The AM was manually separated from the chorion, extensively washed and treated with antibiotic and antifungal solutions. hAECs from different regions were prepared as described by Magatti et al.²⁵ Briefly, AM fragments were incubated in 1× PBS (Sigma-Aldrich, St. Louis, MO, USA) containing 0.5 mM ethylenediaminetetraacetic acid (EDTA) (Sigma-Aldrich) and 100 U/mL penicillin plus 100 mg/mL streptomycin (P/S, Sigma-Aldrich) for 10 min at 37 °C and then in 1× trypsin/EDTA solution (Sigma-Aldrich; 10 mL for each fragment) for 5 min at 37 °C. After discarding debris, the fragments were incubated once more in fresh trypsin/EDTA solution for 10 min at 37°C, after which the tissue was carefully shaken and the trypsin was inactivated by adding 3 to 4 volumes of Roswell Park Memorial Institute (RPMI) 1640 medium (Sigma-Aldrich), supplemented with 10% heat-inactivated fetal bovine serum (FBS, Sigma-Aldrich), 2 mM l-glutamine (Sigma-Aldrich), and P/S (i.e., RPMI complete medium). The fragments were then washed twice in PBS and digested a third time in trypsin/EDTA. The cells from the second and third digests were pooled and centrifuged at 300× g for 10 min. Cell suspensions were then filtered through a 70-µm cell strainer (BD Biosciences, San Jose, CA, USA), centrifuged, and counted.

Flow Cytometry

AECs isolated from different placental regions were washed with FACS buffer (0.1% sodium azide [Sigma-Aldrich] and 0.1% FBS [Sigma-Aldrich] in PBS) and then incubated for 20 min at 4 °C with anti-human fluorescein isothiocyanate (FITC), phycoerythrin (PE), or allophycocyanin (APC)-conjugated monoclonal antibodies, or isotype-matched controls specified below, together with 20 mg/mL polyglobin (Kiovig, Baxter, Kiogiv, Baxter, Deerfield, IL, USA), which was prepared in PBS with 1% bovine serum albumin (BSA) and added to block nonspecific binding.

The clones and suppliers of the antibodies used in this study were as follows: monoclonal antibodies against CD90 (5E10), CD105 (266), CD73 (AD2), CD140b (28D4), CD146 (P1H12), CD45 (2D1), human leukocyte antigen (HLA)-ABC (G46-2.6), HLA-DR (TU36), stage-specific embryonic antigen (SSEA)-4 (MC813-70) (all purchased from BD Biosciences); CD326 (HEA-125) and CD324 (67A4) (both purchased from Miltenyi Biotec, Bergisch Gladbach, Germany); TRA-1-60 (TRA-1-60, purchased from Millipore); and CD49a (TS2/7, purchased from AbD Serotec, Oxford, UK).

FITC/PE/APC/Alexa-488 or Alexa-647-conjugated mouse IgG1, IgG2b, and rat IgG2a were used as isotype controls; all antibodies were obtained from BD Biosciences, except for Alexa-488 and APC-conjugated mouse IgG2b and Alexa-647-conjugated rat IgG2a and IgG3 isotype control, which were purchased from AbD Serotec.

Colony-Forming Unit (CFU) assay

CFU assays were performed in 6-well plates using freshly isolated AECs from 4 different placental regions. Cells were seeded at 2 different densities (1 × 10⁴ and 2×10⁴ cells/well) in Dulbecco's modified Eagle's medium (DMEM) F-12 (Gibco Life Technologies, Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% FBS, 100 U/mL penicillin, 100 μg/mL streptomycin, 2 mM l-glutamine, and 10 ng/mL epidermal growth factor (EGF) (Sigma-Aldrich). After 2 wk in culture, cells were fixed and stained with DiffQuick (BIOMAP SNC Agrate Brianza [MB], Italy). Clusters with at least 30 cells were considered colonies.

Osteogenic Differentiation of AECs

AECs were seeded in 48-well plates at a density of 5×10⁴/cm² in DMEM F-12 (Life Technologies) supplemented with 10% FBS, 100 U/mL penicillin, 100 μg/mL streptomycin, 2 mM l-glutamine, and 10 ng/mL EGF. After 4 d, culture medium was replaced with medium from STEMPRO® Osteogenesis Differentiation Kit (Life Technologies) and then subsequently replaced twice a week. Osteogenic differentiation was assessed after 14 d, and calcium deposits were visualized using the Alizarin Red and Von Kossa methods. Cells were fixed in 10% formalin and 2% Alizarin Red pH 4.2 was added, left for 25 min, and afterward cells were washed with distilled water. Alternatively, cells were fixed in 10% formalin and 5% silver nitrate (Sigma-Aldrich) was added for 1 h under ultraviolet light, washed with water, and incubated with 5% sodium thiosulfate (Sigma-Aldrich) for 5 min and washed once more.

Statistical Analysis

Data are expressed as mean ± standard deviation (SD). Student t-test or one-way analysis of variance (ANOVA) were used for statistical comparisons. Statistical significance was defined as P < 0.05.

Results

The Histological Structure of Human AM

We first performed a morphological study of the whole AM in correspondence of the chorion frondosum and chorion laeve. Figure 1A shows a 2-D reconstruction of the placenta structure, from the superficial to the innermost layers. The superficial layer is the AM, including an epithelial layer and an underlying connective tissue. The epithelial layer contains cells of different height with nuclei in central or apical position (Fig. 1B). These cells are named hAECs, while human AMSCs are detected below the basement membrane. As shown in Figure 1B, AECs display different morphological features in the different areas of AM. In all the areas of AM, the amniotic epithelium appears multilayered except for the intermediate area (Fig. 1B). In the central area, the nuclei of epithelial cells are located in a higher position than in the other areas and, occasionally, budding or detaching cells are present (Fig. 1B). Interestingly, apoptotic cells, which were completely detached from AM and with apoptotic bodies in the cytoplasm, were mainly observed in the central area (Fig. 1B), although budding and detaching cells were present also in other areas, including the reflected area (Fig. 1B).

Figure 1.

(A) The histological structure of the human placenta. Representative 2-D reconstruction of the human placenta, stained with trichrome Mallory solution (original magnification: ×2.5), and schematic representation of the placental structure. AE, amniotic epithelium; AM, amniotic mesenchyme; Ch, chorion; D, decidua. In the right panels, details are shown at a higher magnification (×10 and ×40). (B) The histological structure of the different areas of the human amniotic membrane. The pictures show the amniotic epithelium and the underlying connective tissue of the central, intermediate, peripheral, and reflected areas. Black arrows point at apoptotic cells, arrowheads point at multilayered epithelium and detaching cells, and green arrows point at budding cells. Sections were stained with hematoxylin–eosin solution (original magnification: ×20).

In Situ Mapping of the AM and Quantification of Pluripotency and Proliferation Markers

We also evaluated the in situ expression of different proteins with the aim to map AM and, eventually, to identify the presence of different cell populations. Specifically, we investigated the expression of OCT-4, c-KIT, SOX-2, α-fetoprotein, CREB, and p-CREB with immunohistochemistry. OCT-4 was detectable at both nuclear and cytoplasmic levels in AECs belonging to all the 4 areas of AM. Moreover, it was clearly expressed by AMSCs from all the different areas (Fig. 2). By contrast, c-KIT was detectable only in the peripheral and reflected areas mainly at cytoplasmic level (Fig. 2); SOX-2 and α-fetoprotein were also expressed at cytoplasmic level, but in all the areas and in both cell populations (AECs and AMSCs; Fig. 2). Interestingly, we observed that AECs express CREB, a nuclear transcription factor involved in cell apoptosis, proliferation, and differentiation, at the nuclear level in the central and intermediate area (Fig. 2) and both at the cytoplasmic and nuclear levels in the peripheral and reflected areas (Fig. 2). In all the areas, p-CREB was expressed at the nuclear level (Fig. 2). AMSCs from all the areas were also positive for CREB and occasionally positive for p-CREB (Fig. 2). To exclude the presence of unspecific reactions, we labeled sections from liver or renal tissue in parallel with AECs isolated from the 4 areas of AM. The results obtained confirmed the specificity of the in situ immunohistochemical reactions (data not shown).

Figure 2.

Immunohistochemistry in light microscopy. Photomicrographs depicting the immunohistochemical reaction for OCT-4, c-KIT, SOX-2, α-fetoprotein, CREB, and p-CREB in the central, intermediate, peripheral, and reflected areas (original magnification: ×40). Black arrows point at human amniotic mesenchymal stromal cells (AMSCs). The insets show the negative control of the reaction for all antibodies (original magnification: ×40).

We quantified the immunohistochemical reactions through a morphometric analysis with MetaMorph analysis software (Fig. 3A and B). We selected for each labeled sample the same area (3,000 μm²) and applied the same discrimination threshold in order to have comparable results (Fig. 3A). In particular, the labeling for OCT-4 was higher in the peripheral area followed by the reflected area in comparison with both the central (P < 0.05) and intermediate areas (Supplementary Fig. 1S). Similarly, both c-KIT and SOX-2 expression reached the highest level in the peripheral area, and c-KIT expression was less intense in the intermediate area than in the central and reflected areas, while SOX-2 expression was less intense in the reflected area than in the central and intermediate areas (Supplementary Fig. 1S). Instead, the highest α-fetoprotein expression was found both in the central and in the peripheral areas (P < 0.05; Supplementary Fig. 1S). Consistently, both total CREB and p-CREB expression were found to be increased in the peripheral area in comparison to the central (P < 0.05), intermediate, and reflected areas (Supplementary Fig. 1S). In conclusion, the highest expression of OCT-4, c-KIT, SOX-2, and CREB was in the peripheral area, while the α-fetoprotein highest expression was in the central area. In particular, the highest positivity for OCT-4 and CREB in the peripheral area indicates that mostly in this area AECs have properties of stemness, proliferation, and differentiation capability. In line with these observations, morphometric analysis on semithin sections displayed a progressively increasing content of lipid granules toward the peripheral area (Supplementary Fig. 2S).

Figure 3.

Quantification and statistical analysis of immunohistochemical reactions. (A) Light microscopy image representative of the method used for quantitative analysis of the immunohistochemical reactions with MetaMorph analysis software (original magnification: ×40). The selected area for each sample was 3,000 μm². (B) Bar graph representation of the immune labeling for OCT-4, SOX-2, c-KIT, α-fetoprotein, CREB, and p-CREB in the central (C), intermediate (I), peripheral (P), and reflected (R) areas of the amniotic membrane. Values reported in the bar graphs are the means ± standard deviation (SD) of labeled area from at least 3 different experiments.*P < 0.05: OCT-4 central area versus peripheral area, α-fetoprotein intermediate area versus peripheral area, and CREB central area versus peripheral area.

Phenotypic Markers of Cells Isolated from Different Placental Regions

After having observed differences in AECs in situ, we isolated AECs from distinct regions of the AM and performed flow cytometry analysis. AECs were isolated from different placental regions and analyzed for typical cell surface protein expression (Table 1) of (a) epithelial cell markers: CD324 (E-cadherin), CD326 (EpCAM), and CD73; (b) embryonic markers: SSEA-4 and human stem cell marker TRA-1-60; (c) mesenchymal markers: CD90 (Thy-1) and CD105 (endoglin); (d) pericyte-associated markers: CD146 and CD140b (platelet-derived growth factor receptor [PDGFRb]) (e) integrin CD49a; (f) HLA-ABC class I histocompatibility antigens and HLA-DR class II histocompatibility antigens; and (g) the hematopoietic marker CD45.

Table 1.

Phenotype of AECs Isolated from Different Regions of the Human Amniotic Membrane.

	Central % Mean	SD	Intermediate % Mean	SD	Peripheral % Mean	SD	Reflected % Mean	SD
CD324 (E-Caderin)	98.66	1.14	98.71	1.04	98.91	0.90	99.30	0.52
CD326 (EpCam)	67.33	30.39	65.57	32.76	54.28	39.73	77.44	33.97
CD73	98.65	0.43	98.89	0.80	98.59	1.60	96.99	4.19
SSEA-4	72.59	24.72	80.68	11.08	87.94	4.23	92.30	5.20
TRA-1-60	9.49	10.94	12.87	9.90	12.61	15.44	4.67	6.73
CD90 (Thy-1)	1.13	0.60	0.65	0.21	0.86	0.47	0.54	0.15
CD105 (Endoglin)	0.22	0.16	0.42	0.42	0.20	0.03	0.29	0.35
CD146	1.00	0.59	0.49	0.37	0.56	0.32	0.50	0.47
CD140b (PDGFRb)	7.29	5.87	2.66	1.90	2.34	1.58	2.48	2.15
CD49a (Integrin A1)	7.30	2.72	11.10	3.13	10.41	3.83	7.33	4.52
HLA-ABC	62.70	15.56	55.45	16.05	59.30	14.45	81.63	16.47
HLA-DR	0.88	0.55	0.92	0.43	0.65	0.43	0.84	0.68
CD45	1.00	0.30	0.90	0.31	0.60	0.23	0.81	0.65

Note: Percentage of positive amniotic epithelial cells (AECs) for the indicated markers. Mean and standard deviation (SD) of at least 3 experiments.

In line with our previous reports, AECs from all the 4 regions expressed CD324, CD326, CD73, and SSEA-4 and TRA-1-60 (Table 1). Furthermore, AECs had low/absent expression of mesenchymal markers CD90, CD105, pericyte-associated markers CD146 and CD140b (PDGFRb), and CD49a integrin. We also confirmed that AECs do not express the hematopoietic marker CD45 but are positive for HLA-ABC, also in line with previous reports. No significant differences were observed between regions for any markers analyzed.

CFU Ability of AECs from Different Regions of the AM

CFU assays were performed using AECs from all 4 placental regions to analyze their clonogenic potential (Fig. 4A). The results obtained show that for both AEC concentrations seeded (1 × 10⁴ and 2 × 10⁴), cells found in the reflected area had a higher mean CFU value compared to the other 3 areas (Fig. 4). This difference was significant versus the peripheral, intermediate, and central areas when the lower AEC concentration was tested (P < 0.01 vs. peripheral and intermediate; P < 0.05 vs. central) versus the peripheral and intermediate areas when the highest AEC concentration was used (P < 0.05 vs. peripheral; P < 0.01 vs. intermediate).

Figure 4.

(A): Colony-forming unit assay of amniotic epithelial cells (AECs) isolated from different regions of the amniotic membrane: 1 × 10⁴ or 2 × 10⁴ AECs were seeded per well. Graphs represent mean and standard error mean (SEM). Statistical analysis was performed using GraphPad v6 by a 1-way analysis of variance followed by the Bonferroni multicomparisons test. (B) Osteogenic differentiation of AECs isolated from different regions of the amniotic membrane. Representative images of osteogenic differentiation of AECs evaluated through calcium deposit staining with Alizarin red and Von Kossa staining methods (original magnification: ×4).

Osteogenic Differentiation of AECs from Different Regions of the AM

AECs were also investigated for their capacity to differentiate into osteoblasts through Alizarin red staining. AECs from all the 4 regions showed positive Alizarin red and Von Kossa staining, with the exception of the central and peripheral areas, which macroscopically had less positive staining (Fig. 4B). According to morphometric analysis, AECs were able to undergo osteogenic differentiation more in the intermediate area than in the other areas (Fig. 4B). The differentiation potential was also significantly higher in the reflected area, whereas the peripheral area (P < 0.05) showed the lowest osteogenic potential (Fig. 4B).

Discussion

Herein, we sought to map different areas of the human AM in situ and also characterize epithelial cells isolated from different regions of the AM. It has been widely recognized that AM can exert anti-inflammatory, antiangiogenic, antifibrotic, and antimicrobial effects^12,27. A number of clinical studies have used the AM for applications in regenerative medicine^17,28
–30, but it has yet to be elucidated whether the different areas of the placenta have the same plasticity and differentiation potential. One study has recently demonstrated that placental amnion possesses a slightly higher metabolic activity and significantly lower ROS content, when compared to reflected amnion, which could suggest diverse cell differentiation capacities between the 2 regions²⁰. To map the AM in situ, we established 4 different regions according to their position relative to umbilical cord: the first area, closer to umbilical cord, was named the central area; the second, in the middle, was considered the intermediate area; the third was the peripheral area (all the 3 areas were part of the chorion frondosum); and the fourth, the reflected area, corresponded to the chorion laeve. Our results demonstrate the presence of a multilayered epithelium in different areas of the AM, except for the intermediate area, with a number of budding or detaching cells as well as apoptotic cells, especially in the central area. Remarkably, the central area, located near the umbilical cord, showed many morphological differences in comparison with other areas of AM. We evaluated the expression of different proteins and observed that the peripheral and reflected areas have the highest OCT-4 and SOX-2 expression in situ, well-known indicators of pluripotency. These observations are consistent with results obtained using CFU assays and have been shown in previous reports^31
–33. Furthermore, the peripheral area also expressed the highest levels of CREB and its active form p-CREB, well known for its key role in a number of processes including proliferation, differentiation, and apoptosis^34
–36. According to electron microscopy preparations, the AECs from the peripheral area display the highest quantity of lipid granules in the cytoplasm. Although further studies are needed to characterize granule content, our findings suggest that this area could be the most capable of immune-modulatory effects since a number of reports have attributed these effects to prostaglandin E secretion by AM^37,38. Interestingly, high levels of α-fetoprotein were found in the central area and, to a lesser extent, in the peripheral area, suggesting that these areas could be more prone to hepatic differentiation. There are a number of published studies demonstrating the capability for AECs to differentiate into hepatocytes in vitro and in vivo and their translational use in the treatment of hepatic diseases^24,39,40. We can speculate that enhanced effects could be obtained by inducing hepatocyte differentiation using an enriched population selected from the central area of the AM. To characterize the differentiation potential of the different areas of the AM, AECs were first isolated and phenotypically characterized demonstrating the expression of typical epithelial cell markers (CD324, CD326, and CD73) as well as of embryonic markers (SSEA-4 and TRA-1-60) with no significant differences among the different areas. This finding could suggest that AECs are a relatively homogeneous population, at least at the cell surface antigen level or rather that the technical procedures used herein to isolate AECs from AM could in some way artifactually unify the phenotypic pattern. Actually, when induced osteogenically, AECs from the intermediate area showed the highest osteogenic potential in terms of in vitro mineralization assays. This feature has already been demonstrated by other authors concerning the whole AM^41

–44 together with the capability to differentiate into cells derived from all the 3 germ layers both in vitro and in vivo.

Our innovative findings highlight that AECs belonging to the AM are a heterogeneous stem cell population since they display (i) different expression of pluripotency and proliferation (OCT-4, c-KIT, SOX-2, α-fetoprotein, CREB, and p-CREB) markers, (ii) different proliferation capability, and (iii) different osteogenic potential in the different areas. This should be taken into account to increase efficiency of AM application within a therapeutic context.

Conclusion

Our study is the first to perform a detailed in situ phenotypic mapping of AM of human placenta and to demonstrate that epithelial cells in different areas of AM possess different characteristics. In fact, AECs from 4 distinct areas of AM have different morphology, expression of pluripotency markers and differentiation capabilities. On the one hand, this study consolidates the evidence of the already reported heterogeneity of the AEC population. On the other hand, our study provides important information on cell localization and distinct features which can be attributed to these cells and, if demonstrated to correlate with different therapeutic potential, could suggest the use of cells from a specific region described herein for regenerative medicine purposes.

Supplemental Material

Supplemental Material, supp - Mapping of the Human Placenta: Experimental Evidence of Amniotic Epithelial Cell Heterogeneity

Supplemental Material, supp for Mapping of the Human Placenta: Experimental Evidence of Amniotic Epithelial Cell Heterogeneity by Lucia Centurione, Francesca Passaretta, Maria Antonietta Centurione, Silvia De Munari, Elsa Vertua, Antonietta Silini, Marco Liberati1, Ornella Parolini, and Roberta Di Pietro in Cell Transplantation

Footnotes

Authors’ Note

Lucia Centurione and Francesca Passaretta contributed equally to this work.

Acknowledgments

The authors wish to thank Dr. Fabio Marongiu for helpful discussions. We thank all the amniotic membrane donors and the Hospitals of Chieti and Brescia for their kind cooperation.

Author Contributions

L. Centurione contributed to conception and design and collection of data; F. Passaretta contributed to collection of data and manuscript writing; M. Antonietta Centurione contributed to collection of data; S. De Munari performed experiments; E. Vertua performed experiments; A. Silini contributed to data analysis and manuscript preparation; M. Liberati contributed to helping in the provision of amniotic membrane samples; O. Parolini contributed to data analysis and interpretation and final approval of the manuscript; R. Di Pietro contributed to data analysis and interpretation and manuscript critical revision.

Ethical Approval

This study was approved by our institutional review board.

Statement of Human and Animal Rights

Samples were collected after obtaining informed written consent according to the guidelines set by the Ethics Committee for the Institution of Catholic Hospitals or the G. d'Annunzio University of Chieti–Pescara.

Statement of Informed Consent

Declaration of Conflicting Interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by MIUR (Italian Ministry of University and Research) funds granted to Professor Roberta Di Pietro in 2014 and 2015 and by Fondazione Poliambulanza-Istituto Ospedaliero, Brescia, Italy.

Supplemental Material

The online data supplements for this article are available online.

References

Parolini

Alviano

Bagnara

Bilic

Bühring

Evangelista

Hennerbichler

Liu

Magatti

Mao

Miki

Marongiu

. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells. 2008;26(2):300–311.

In’t Anker

Scherjon

Kleijburg-van der Keur

de Groot-Swings

Claas

Fibbe

Kanhai

. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells. 2004;22(7):1338–1345.

Macias

Grande

Moreno

Domínguez

Bornstein

Flores

. Isolation and characterization of true mesenchymal stem cells derived from human term decidua capable of multilineage differentiation into all 3 embryonic layers. Am J Obstet Gynecol. 2010;203(5):495.e499–495.e423.

Wang

Hung

Peng

Huang

Wei

Guo

Lai

Chen

. Mesenchymal stem cells in the Wharton’s jelly of the human umbilical cord. Stem Cells. 2004;22(7):1330–1337.

La Rocca

Anzalone

Corrao

Magno

Loria

Lo Iacono

Di Stefano

Giannuzzi

Marasà

Cappello

Zummo

Farina

. Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochem Cell Biol. 2009;131(2):267–282.

Igura

Zhang

Takahashi

Mitsuru

Yamaguchi

Takashi

. Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta. Cytotherapy. 2004;6(6):543–553.

Abumaree

Al Jumah

Kalionis

Jawdat

Al Khaldi

AlTalabani

Knawy

. Phenotypic and functional characterization of mesenchymal stem cells from chorionic villi of human term placenta. Stem Cell Rev. 2013;9(1):16–31.

Roselli

Lazzati

Iseppon

Manganini

Marcato

Gariboldi

Maggi

Grati

Simoni

. Fetal mesenchymal stromal cells from cryopreserved human chorionic villi: cytogenetic and molecular analysis of genome stability in long-term cultures. Cytotherapy. 2013;15(11):1340–1351.

Soncini

Vertua

Gibelli

Zorzi

Denegri

Albertini

Wengler

Parolini

. Isolation and characterization of mesenchymal cells from human fetal membranes. J Tissue Eng Regen Med. 2007;1(4):296–305.

10.

Paradowska

Blach-Olszewska

Gejdel

. Constitutive and induced cytokine production by human placenta and amniotic membrane at term. Placenta. 1997;18(5–6):441–446.

11.

Steed

Trumpower

Duffy

Smith

Marshall

Rupp

Robson

. Amnion-derived cellular cytokine solution: a physiological combination of cytokines for wound healing. Eplasty. 4 2008;8:e18.

12.

Silini

Cargnoni

Magatti

Pianta

Parolini

. The long path of human placenta, and its derivatives, in regenerative medicine. Front Bioeng Biotechnol. 2015;3:162.

13.

Cargnoni

Di Marcello

Campagnol

Nassuato

Albertini

Parolini

. Amniotic membrane patching promotes ischemic rat heart repair. Cell Transplant. 2009;18(10):1147–1159.

14.

Sant’Anna

Cargnoni

Ressel

Vanosi

Parolini

. Amniotic membrane application reduces liver fibrosis in a bile duct ligation rat model. Cell Transplant. 2011;20(3):441–453.

15.

Ricci

Vanosi

Lindenmair

Hennerbichler

Peterbauer-Scherb

Wolbank

Cargnoni

Signoroni

Campagnol

Gabriel

Redl

Parolini

. Anti-fibrotic effects of fresh and cryopreserved human amniotic membrane in a rat liver fibrosis model. Cell Tissue Bank. 2013;14(3):475–488.

16.

Roy

Haase

Bader

Becker

Seifert

Choi

Falk

Stamm

. Decellularized amniotic membrane attenuates postinfarct left ventricular remodeling. J Surg Res. 2016;200(2):409–419.

17.

Lakshmi

Bharani

Ambardar

. Repair of an oroantral communication by a human amniotic membrane: a novel technique. J Korean Assoc Oral Maxillofac Surg. 2015;41(4):194–197.

18.

Kozlowska-Rup

Czekaj

Plewka

Sikora

. Immunolocalization of ABC drug transporters in human placenta from normal and gestational diabetic pregnancies. Ginekol Pol. 2014;85(6):410–419.

19.

McParland

Taylor

Bell

. Mapping of zones of altered morphology and chorionic connective tissue cellular phenotype in human fetal membranes (amniochorion and decidua) overlying the lower uterine pole and cervix before labor at term. Am J Obstet Gynecol. 2003;189(5):1481–1488.

20.

Banerjee

Weidingera

Steinbornc

Steinborn

Lindenmair

Hennerbichler-Lugscheider

Eibl

Redl

Kozlov

Wolbank

. Different metabolic activity in placental and reflected regions of the human amniotic membrane. Placenta. 2015;36(11):1329–1332.

21.

Manuelpillai

Moodley

Borlongan

Parolini

. Amniotic membrane and amniotic cells: potential therapeutic tools to combat tissue inflammation and fibrosis? Placenta. 2011;32(Suppl 4): S320–S325.

22.

Alcaraz

Mrowiec

Insausti

García-Vizcaíno

Ruiz-Canada

López-Martínez

Moraleda

Nicolás

. Autocrine TGF-β induces epithelial to mesenchymal transition in human amniotic epithelial cells. Cell Transplant. 2013;22(8):1351–1367.

23.

Bilic

Zeisberger

Mallik

Zimmermann

Zisch

. Comparative characterization of cultured human term amnion epithelial and mesenchymal stromal cells for application in cell therapy. Cell Transplant. 2008;17(8):955–968.

24.

Marongiu

Gramignoli

Dorko

Miki

Ranade

Paola Serra

Doratiotto

Sini

Sharma

Mitamura

Sellaro

Tahan

. Hepatic differentiation of amniotic epithelial cells. Hepatology. 2011;53(5):1719–1729.

25.

Magatti

Caruso

De Munari

Vertua

Manuelpillai

Parolini

. Human amniotic membrane-derived mesenchymal and epithelial cells exert different effects on monocyte-derived dendritic cell differentiation and function. Cell Transplant. 2015;24(9):1733–1752.

26.

Tahan

. Placental amniotic epithelial cells and their therapeutic potential in liver diseases. Front Med (Lausanne). 2014;8(1):48.

27.

Miki

. Amnion-derived stem cells: in quest of clinical applications. Stem Cell Res Ther. 2011;2(3):25.

28.

Díaz-Prado

Muiños-López

Hermida-Gómez

Rendal-Vázquez

Fuentes-Boquete

de Toro

Blanco

. Multilineage differentiation potential of cells isolated from the human amniotic membrane. J Cell Biochem. 2010;111(4):846–857.

29.

Zelen

Serena

Snyder

. A prospective, randomised comparative study of weekly versus biweekly application of dehydrated human amnion/chorion membrane allograft in the management of diabetic foot ulcers. Int Wound J. 2014;11(2):122–128.

30.

Liu

Cao

Guo

Zhuang

. Amniotic stem cell transplantation therapy for type 1 diabetes: a case report. J Int Med Res. 2013;41(4):1370–1377.

31.

Ghosh

Selokar

Gahlawat

Kumar

Yadav

. Amnion epithelial cells of buffalo (Bubalus bubalis) term placenta expressed embryonic stem cells markers and differentiated into cells of neurogenic lineage in vitro. Anim Biotechnol. 2016;27(1):38–43.

32.

Barboni

Russo

Curini

Martelli

Berardinelli

Mauro

Mattioli

Marchisio

Bonassi Signoroni

Parolini

Colosimo

. Gestational stage affects amniotic epithelial cells phenotype, methylation status, immunomodulatory and stemness properties. Stem Cell Rev. 2014;10(5):725–741.

33.

Roubelakis

Trohatou

Anagnou

. Amniotic fluid and amniotic membrane stem cells: marker discovery. Stem Cells Int. 2012;2012:107836.

34.

Di Nisio

Sancilio

Di Giacomo

Rapino

Sancillo

Genovesi

Di Siena

Rana

Cataldi

Di Pietro

Involvement of cyclic-nucleotide response element-binding family members in the radiation response of Ramos B lymphoma cells. Int J Oncol. 2016;48(1):28–36.

35.

Caravatta

Sancilio

di Giacomo

Rana

Cataldi

Di Pietro

. PI3-K/Akt-dependent activation of cAMP-response element-binding (CREB) protein in Jurkat T leukemia cells treated with TRAIL. J Cell Physiol. 2008;214(1):192–200.

36.

Di Pietro

di Giacomo

Caravatta

Sancilio

Rana

Cataldi

. Cyclic nucleotide response element binding (CREB) protein activation is involved in K562 erythroleukemia cells differentiation. J Cell Biochem. 2007;100(4):1070–1079.

37.

Park

Lee

Min

. Identification of novel membrane-associated prostaglandin E synthase-1 (mPGES-1) inhibitors with anti-influenza activities in vitro. Biochem Biophys Res Commun. 2016;469(4):848–855.

38.

Kang

Koo

Hwang

Kang

Lee

Park

. Immunomodulatory effects of human amniotic membrane-derived mesenchymal stem cells. J Vet Sci. 2012;13(1):23–31.

39.

Vaghjiani

Vaithilingam

Saraswati

Sali

Murthi

Kalionis

Tuch

Manuelpillai

. Hepatocyte-like cells derived from human amniotic epithelial cells can be encapsulated without loss of viability or function in vitro. Stem Cells Dev. 2014;23(8):866–876.

40.

Marongiu

Serra

Contini

Sini

Strom

Laconi

Marongiu

. Rat-derived amniotic epithelial cells differentiate into mature hepatocytes in vivo with no evidence of cell fusion. Stem Cells Dev. 2015;24(12):1429–1435.

41.

Ilancheran

Michalska

Peh

Wallace

Pera

Manuelpillai

. Stem cells derived from human fetal membranes display multilineage differentiation potential. Biol Reprod. 2007;77(3):577–588.

42.

Jiawen

Jianjun

Jiewen

Dedong

Hongbo

Jun

Xudong

Shen

Lihe

. Osteogenic differentiation of human amniotic epithelial cells and its application in alveolar defect restoration. Stem Cells Transl Med. 2014;3(12):1504–1513.

43.

Lindenmair

Nürnberger

Stadler

Meinl

Hackl

Eibl

Gabriel

Hennerbichler

Redl

Wolbank

. Intact human amniotic membrane differentiated towards the chondrogenic lineage. Cell Tissue Bank. 2014;15(2):213–225.

44.

Wang

Han

Zheng

Lei

Chen

Luo

Liu

. Osteogenic differentiation of amniotic epithelial cells: synergism of pulsed electromagnetic field and biochemical stimuli. BMC Musculoskelet Disord. 2014;15:271.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.54 MB